Steve Curtis
InvestorManaging Director, Director of New Ventures at BrightEdge
Find your path to Steve
6 people in our graph share verified history with Steve — schools, employers, funds. One of them is your warm intro.
Caitlin TolmanunlockedSteve: together at BrightEdge
×5Steve: together at BrightEdge
About
Steve Curtis is Director of New Ventures at BrightEdge, the impact venture capital arm of the ACS. He previously managed MPM Capital's Oncology Innovations Fund, a venture/philanthropy collaboration with Dana-Farber Cancer Institute, where he invested in seed and Series A biotech companies. Earlier roles include Senior Director of Business Development at Eli Lilly, co-leading the Bioscience Ventures group at 2M Companies, and running technology in-licensing at Reata Pharmaceuticals.
Invests in
BiotechImpact & Social Good
Colleagues at BrightEdge
Frequently asked questions
- Who is Steve Curtis?
- Steve Curtis is Director of New Ventures at BrightEdge, the impact venture capital arm of the ACS. He previously managed MPM Capital's Oncology Innovations Fund, a venture/philanthropy collaboration with Dana-Farber Cancer Institute, where he invested in seed and Series A biotech companies. Earlier roles include Senior Director of Business Development at Eli Lilly, co-leading the Bioscience Ventures group at 2M Companies, and running technology in-licensing at Reata Pharmaceuticals.
- Where does Steve Curtis work?
- Steve Curtis is Managing Director, Director of New Ventures at BrightEdge.
- What does Steve Curtis invest in?
- Steve Curtis invests in Biotech, Impact & Social Good.